Protalix Biotherapeutics, Inc. (PLX)
2.70
-0.10
(-3.57%)
USD |
NYAM |
Feb 10, 16:00
2.75
+0.05
(+1.85%)
After-Hours: 20:00
Protalix Biotherapeutics Market Cap : 217.14M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 3.095B |
| OraSure Technologies, Inc. | 201.57M |
| PAVmed, Inc. | 10.10M |
| Agenus, Inc. | 104.41M |
| Curis, Inc. | 12.93M |
Market Cap Related Metrics
| PE Ratio | 38.85 |
| PS Ratio | 3.433 |
| Price to Book Value | 4.104 |
| Price | 2.70 |
| Earnings Yield | 2.57% |
| Operating PE Ratio | 33.35 |
| Normalized PE Ratio | 38.85 |